Home
Cormorant Global Healthcare Master Fund, 10% Owner: Ambrx Biopharma AMAM Buy · Filed 23/04/17
Trade details
- Type
- Insider buy
- Amount
- $8,385,991.32
- Shares · price
- 841,967 sh · $9.96 a share
- Held after
- 61,535,775 sh
- Stock
- Ambrx Biopharma AMAM
- Trade date
- 23/04/14
- Filed
- 23/04/17
- Days to filing
- 3 days
4 insiders bought this week
- Insiders buying this week
- 4 insiders
- Holding change
- +1.4%
Ambrx Biopharma trades, last 26 weeks
What else happened in Ambrx Biopharma around then
Filed or reported within 30 days of the trade day · 23/03/15~23/05/14Cormorant Global Healthcare Master Fund's recent trades
- Cormorant Global Healthcare Master Fund
SellBright Minds Biosciences
SellBright Minds Biosciences
DRUG
$9.8M
109,331 sh
$9.8M
Filed 04/30
Traded 04/28
- Cormorant Global Healthcare Master Fund
SellCorbus Pharmaceuticals Holdings
SellCorbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
- Cormorant Global Healthcare Master Fund
SellEyePoint
SellEyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
- Cormorant Global Healthcare Master Fund
SellMoonLake Immunotherapeutics
SellMoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
- Cormorant Global Healthcare Master Fund
SellMoonLake Immunotherapeutics
SellMoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29
